Abstract:Purpose Dopamine transporter (DAT) is a promising target for positron emission tomography (PET) imaging of many neuropsychiatric diseases. 18 F-labelled N-alkyl tropane analogues were reported to be useful PET radioligands for DAT. However, the drawback of 18 F-labelled tropane analogues is that N -alkyl on tropane is easily metabolized in vivo , which interferes with brain imaging. To develop a more in vivo stable DAT-targeted PET radioligand with high DAT affinity and specificity, in this study, we synthesized and compared a series of 18 F-labelled novel deuterated N-fluoropropyl tropane derivatives [ 18 F] 4a-e for DAT tracing. Procedures Five deuterated N-fluoropropyl-d 6 tropane derivatives ( 4a-e ) and corresponding non-deuterated compounds ( 6a-e ) were synthesized, and their semi-inhibitory concentrations (IC 50 ) were measured by competitive binding assay. The radioligands [ 18 F] 4a-e and [ 18 F] 6a-e were obtained by two-step one-pot radio-labelling reactions. The selectivity and specificity of these radioligands were evaluated by cellular uptake and microPET in normal rats. [ 18 F] 4e was selected for further investigation with microPET of the PD model, autoradiography and biodistribution experiments and compared with its non-deuterated [ 18 F] 6e . Finally, in vivo metabolic stability was analyzed by radio-HPLC. Results Ten tropane compounds had high DAT affinity (IC 50 = 2–21 nM), in which FP-CIT-d 6 ( 4e ) had the lowest IC 50 value of 2.7 nM. Radiolabelled [ 18 F] 4a-e and [ 18 F] 6a-e were obtained with radiochemical yields ranging from 10.6 ± 2.8% to 35.1 ± 5.4% with molar activities >20 GBq/μmol and the radiochemical purities >99%. [ 18 F] 4e showed the highest cell uptake (12%) and CFT inhibition efficacy (∼72%) among [ 18 F] 4a-e . MicroPET results showed [ 18 F] 4e has the highest target to non-target ratio (striatum/cerebellum). Therefore, [ 18 F] 4e was then selected for further biological evaluation. Ex vivo autoradiography experiment confirmed high specific binding of [ 18 F] 4e towards DAT. Biodistribution results indicated that [ 18 F] 4e has a higher striatum/cerebellum value than [ 18 F]FP-CIT ([ 18 F] 6e ) at 30–120 min. Furthermore, in vivo metabolism studies in rats revealed improved stability of [ 18 F] 4e as compared with that of [ 18 F] 6e . Conclusions The new probe [ 18 F] 4e is a promising candidate with good DAT affinity, specificity and metabolic stability for PET imaging, and might provide reliable diagnosis, treatment and prognostic detection of DAT-related neuropsychiatric diseases.

SYNTHESIS, LABELING AND BIODISTRIBUTION OF TECHNETIUM-99-LABELED BENZTROPINE ANALOGS AS DOPAMINE TRANSPORTER IMAGING AGENTS

Preparation of New Technetium-99m Nns/X Complexes and Selection for Brain Imaging Agent

Synthesis of Labelled Small Peptide Complexes for Imaging Agents with Technetium-99M and Biodistribution in Mice.

Synthesis, Characterization and Biodistribution of A99mtc Nitrido Complex As a Potential Brain Perfusion Imaging Agent

Synthesis and Evaluation of Novel Tropane Derivatives As Potential PET Imaging Agents for the Dopamine Transporter.

Synthesis and Biodistribution of a New 99mtc Nitrido Complex for Brain Imaging

SYNTHESIS OF LABELED PEPTIDE COMPLEXES WITH TECHNETIUM-99m AND BIODISTRIBUTION IN MICE

Imaging Study of Brain Dopamine Transporter Imaging Agent ~(99)Tc~m-Trodat-1

Synthesis and biodistribution of a new 99mTc nitrido complex for cerebral imaging

Synthesis and Biodistribution of Two Novel 99m Tc Nitrido Dithiocarbamate Complexes Containing Heterocyclic Linkage As Potential Brain Perfusion Imaging Agents

Synthesis and Biodistribution of a Novel 99mtc Nitrido Dithiocarbamate Complex Containing Aromatic Group for Cerebral Imaging

Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter

Synthesis and biological evaluation of 18 F-labelled deuterated tropane derivatives as dopamine transporter probes

Synthesis and biodistribution of novel<sup>99m</sup>Tc-nitrido methylpiperidine dithioformate derivatives as potential brain imaging agents

Synthesis of New N2S Ligands, Preparation of 99mtc Complexes and Their Preliminary Biodistribution in Mice

Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.

The Study of Labelling of Dopamine Transporter Imaging Agent ~(99)Tc~m-Trodat-1

SYNTHESIS BIODISTRIBUTION AND QSAR STUDIES OF FIVE Tc-99M LABELED NOVEL N3S PSEUDO-PEPTIDE COMPLEXES

Synthesis and biodistribution of a novel 99m Tc nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent

Synthesis and Biodistribution Of99mtcn(pdtc)2as a Potential Brain Imaging Agent

SYNTHESIS AND RADIOLABELING OF ~(99m)Tc-NITRIDO COMPLEX WITH 4-[(2-METHOXYPHENYL)PIPERAZIN-1-YL]-DITHIOFORMATE AS A POTENTIAL 5-HT_(1A) RECEPTOR IMAGING AGENT